PMID: 9194762Jun 1, 1997Paper

Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study

Arteriosclerosis, Thrombosis, and Vascular Biology
J JeppesenF Gyntelberg

Abstract

High triglyceride (TG) and low HDL cholesterol (HDL-C) is the characteristic dyslipidemia seen in insulin-resistant subjects. We examined the role of this dyslipidemia as a risk factor of ischemic heart disease (IHD) compared with that of high LDL cholesterol (LDL-C) in the Copenhagen Male Study. In total 2910 white men, aged 53 to 74 years, free of cardiovascular disease at baseline, were subdivided into four groups on the basis of fasting concentrations of serum TG, HDL-C, and LDL-C. "High TG-low HDL-C" was defined as belonging to both the highest third of TG and the lowest third of HDL-C; this group encompassed one fifth of the population. "High LDL-C" was defined as belonging to the highest fifth of LDL-C. A control group was defined as not belonging to either of these two groups. "Combined dyslipidemia" was defined as belonging to both dyslipidemic groups. Age-adjusted incidence of IHD during 8 years of follow-up was 11.4% in high TG-low HDL-C, 8.2% in high LDL-C, 6.6% in the control group, and 17.5% in combined dyslipidemia. Compared with the control group, relative risks of IHD (95% confidence interval), adjusted for potentially confounding factors or covariates (age, body mass index, alcohol consumption, physical activi...Continue Reading

References

Dec 14, 1992·The American Journal of Cardiology·W P Castelli
Mar 1, 1990·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·M LaaksoL Mykkänen
Oct 1, 1988·Metabolism: Clinical and Experimental·A GargP Raskin
Oct 7, 1988·JAMA : the Journal of the American Medical Association·M A AustinR M Krauss
Jun 1, 1995·The New England Journal of Medicine·R J Havel, E Rapaport
Nov 1, 1994·Annals of Internal Medicine·B KinosianG Garland
Mar 1, 1994·Atherosclerosis·F KarpeA Hamsten
Apr 1, 1994·International Journal of Epidemiology·P SuadicaniF Gyntelberg
Jul 1, 1993·The Journal of Clinical Investigation·G M ReavenR M Krauss
Apr 29, 1993·The New England Journal of Medicine·M H CriquiC E Davis
Feb 8, 1964·Lancet·G A ROSEE A CROWLEY

❮ Previous
Next ❯

Citations

Jul 31, 2008·International Urology and Nephrology·Hanumanthappa Nandeesha
May 10, 2000·Diabetes Research and Clinical Practice·Y MaenoR Kikkawa
Aug 31, 2001·Journal of the American College of Cardiology·V MohanUNKNOWN Chennai Urban Population Study (CUPS No.5)
Apr 26, 2003·Atherosclerosis. Supplements·Bela F Asztalos, Ernst J Schaefer
Nov 29, 2012·European Journal of Clinical Nutrition·K J Acheson
Mar 5, 2013·Metabolic Syndrome and Related Disorders·Ichiro Wakabayashi
Apr 7, 1999·Current Opinion in Cardiology·L J SemanE J Schaefer
Jun 12, 2004·Current Opinion in Clinical Nutrition and Metabolic Care·Kevin J Acheson
Jan 4, 2007·Diabetes, Obesity & Metabolism·H M F FarinG M Reaven
Jan 8, 2009·International Journal of Clinical Practice·L Cea-CalvoUNKNOWN Investigators of PREV-ICTUS study
Jul 20, 2013·Cardiovascular Diabetology·Tomoko Shimomura, Ichiro Wakabayashi
Feb 24, 2007·Vascular Health and Risk Management·Genovefa D KolovouDennis V Cokkinos
Jul 17, 2008·Vascular Health and Risk Management·Ilan GoldenbergUri Goldbourt
May 14, 2009·Vascular Health and Risk Management·Alan Morrison, John E Hokanson
Jan 1, 2009·Pediatric Reports·Natasa Marcun Varda, Alojz Gregoric
Jan 1, 2010·Journal of Laboratory Physicians·Lorenzo GordonE Martorell
Dec 7, 2013·Journal of Atherosclerosis and Thrombosis·Ichiro Wakabayashi, Takashi Daimon
Dec 17, 2008·Journal of Atherosclerosis and Thrombosis·Akira Yamamoto
Dec 10, 2003·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Maritza PerezPatricio López-Jaramillo
Feb 26, 2008·Journal of Endocrinological Investigation·P A EssahE Carmina
Oct 1, 2007·Biomarkers in Medicine·Nisha I Parikh, Ramachandran S Vasan
Apr 18, 2013·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Ichiro Wakabayashi
Jan 26, 2008·Current Medical Research and Opinion·José V LozanoUNKNOWN Investigators of the PREV-ICTUS Study
Dec 4, 2012·Clinical and Experimental Hypertension : CHE·Zekeriya ArslanKenan Saglam
Mar 18, 2016·International Journal of Food Sciences and Nutrition·Estefania AlsinaSilvia M Friedman
Oct 17, 2014·Metabolic Syndrome and Related Disorders·Ichiro Wakabayashi
Aug 31, 2004·Diabetes Care·Guenther Boden, Markku Laakso
May 27, 2004·Diabetes Care·Ronald M Krauss
Aug 17, 2004·The Medical Clinics of North America·Ronald M Krauss, Patty W Siri
Mar 22, 2005·Archives of Medical Research·Leandro ParzianelloJanice C Coelho
Aug 2, 2005·The American Journal of Cardiology·Tracey McLaughlinRonald M Krauss
May 26, 2009·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Diana R ChirovskyPhilip Barter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.